[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,126,432
  • Shares Outstanding, K 108,098
  • Annual Sales, $ 761,410 K
  • Annual Income, $ 99,650 K
  • EBIT $ 6 M
  • EBITDA $ 3 M
  • 60-Month Beta 0.45
  • Price/Sales 15.88
  • Price/Cash Flow 123.91
  • Price/Book 17.13

Options Overview Details

View History
  • Implied Volatility 45.33% (-2.69%)
  • Historical Volatility 83.26%
  • IV Percentile 11%
  • IV Rank 8.43%
  • IV High 138.94% on 12/15/25
  • IV Low 36.71% on 08/28/25
  • Expected Move (DTE 7) 5.23 (4.73%)
  • Put/Call Vol Ratio 0.54
  • Today's Volume 613
  • Volume Avg (30-Day) 552
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 30,922
  • Open Int (30-Day) 27,731
  • Expected Range 105.28 to 115.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.55
  • Number of Estimates 3
  • High Estimate $0.78
  • Low Estimate $0.26
  • Prior Year $0.16
  • Growth Rate Est. (year over year) +243.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.61 +29.09%
on 07/14/26
122.21 -9.57%
on 07/30/26
+24.61 (+28.65%)
since 07/13/26
3-Month
54.59 +102.44%
on 05/19/26
122.21 -9.57%
on 07/30/26
+53.43 (+93.61%)
since 05/13/26
52-Week
28.66 +285.59%
on 02/19/26
122.21 -9.57%
on 07/30/26
+37.71 (+51.80%)
since 08/13/25

Most Recent Stories

More News
1 Surging Stock to Own for Decades and 2 We Brush Off

1 Surging Stock to Own for Decades and 2 We Brush Off

CORT : 110.51 (-1.49%)
TDW : 91.52 (-0.10%)
KSS : 19.62 (+1.82%)
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation

Corcept Therapeutics (CORT) demonstrates exceptional price momentum with shares up more than 50% over the past year. CORT’s fundamentals are robust with revenue and earnings both projected to grow...

CORT : 110.51 (-1.49%)
3 Cash-Producing Stocks We Steer Clear Of

3 Cash-Producing Stocks We Steer Clear Of

CORT : 110.51 (-1.49%)
LW : 53.78 (+1.26%)
BHE : 80.49 (-1.77%)
Stocks Settle Sharply Higher as Microsoft Leads a Surge in Tech Stocks

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +1.66%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.36%. September E-mini...

MSTR : 97.10 (+2.39%)
SNDK : 1,528.11 (+13.67%)
GLXY : 20.95 (-0.62%)
CROX : 132.56 (+1.49%)
TRI : 106.07 (+3.37%)
COIN : 153.90 (+3.26%)
SBUX : 108.55 (+0.06%)
STX : 921.37 (+4.91%)
WDC : 487.29 (+7.31%)
AMD : 483.01 (+0.02%)
^BTCUSD : 62,781.66 (-0.87%)
EME : 831.23 (-0.26%)
Stocks Rally on Stellar Microsoft Earnings and Chip Stock Strength

The S&P 500 Index ($SPX ) (SPY ) today is up +0.86%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.65%. September E-mini S&P futures...

AMAT : 534.54 (-2.48%)
SNDK : 1,528.11 (+13.67%)
INTU : 358.29 (+7.04%)
CROX : 132.56 (+1.49%)
$SOX : 12,456.00 (+0.46%)
TRI : 106.07 (+3.37%)
$IUXX : 30,084.50 (+1.15%)
FICO : 1,110.70 (+6.37%)
ZNU26 : 108-260 (-0.10%)
MSFT : 496.88 (+0.90%)
ESU26 : 7,829.00 (+0.08%)
SBUX : 108.55 (+0.06%)
Stocks Rebound as Microsoft Earnings Ease AI Spending Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +1.12%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.69%. September E-mini S&P futures...

AMAT : 534.54 (-2.48%)
SNDK : 1,528.11 (+13.67%)
CROX : 132.56 (+1.49%)
$SOX : 12,456.00 (+0.46%)
$IUXX : 30,084.50 (+1.15%)
FICO : 1,110.70 (+6.37%)
ZNU26 : 108-260 (-0.10%)
MSFT : 496.88 (+0.90%)
ESU26 : 7,829.00 (+0.08%)
SBUX : 108.55 (+0.06%)
NCLH : 19.55 (+3.33%)
STX : 921.37 (+4.91%)
Corcept: Q2 Earnings Snapshot

Corcept: Q2 Earnings Snapshot

CORT : 110.51 (-1.49%)
Corcept (NASDAQ:CORT) Reports Bullish Q2 CY2026, Stock Jumps 17.4%

Corcept (NASDAQ:CORT) Reports Bullish Q2 CY2026, Stock Jumps 17.4%

CORT : 110.51 (-1.49%)
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Revenue of $256.1 million, a 32 percent increase over the same period in 2025 Korlym ® and...

CORT : 110.51 (-1.49%)
Corcept's Korlym Defense Unraveling Just as Relacorilant Pipeline Needs to Deliver

Barchart Research What to Expect from CORT Earnings CORT Generated July 28, 2026 Current Price $94.19 EPS Estimate $$-0.04 Consensus Rating Moderate Buy Average Move 4.65% Corcept's Korlym Defense Unraveling...

CORT : 110.51 (-1.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 115.03
2nd Resistance Point 114.02
1st Resistance Point 112.26
Last Price 110.51
1st Support Level 109.49
2nd Support Level 108.48
3rd Support Level 106.72

See More

52-Week High 122.21
Last Price 110.51
Fibonacci 61.8% 86.47
Fibonacci 50% 75.44
Fibonacci 38.2% 64.40
52-Week Low 28.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.